Zelluna ASA (OSL:ZLNA)

Norway flag Norway · Delayed Price · Currency is NOK
13.71
-0.29 (-2.06%)
At close: Jan 13, 2026
-36.81%
Market Cap360.21M
Revenue (ttm)53.00K
Net Income (ttm)-122.19M
Shares Out26.27M
EPS (ttm)-30.91
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,523
Average Volume57,001
Open14.10
Previous Close14.00
Day's Range13.70 - 14.10
52-Week Range8.20 - 22.50
Betan/a
RSI65.10
Earnings DateFeb 12, 2026

About Zelluna ASA

Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company was founded in 2016 and is based in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 22
Stock Exchange Oslo Børs
Ticker Symbol ZLNA
Full Company Profile

Financial Performance

Financial Statements

News

Zelluna ASA (OSL:ZLNA) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial Insights

Zelluna ASA (OSL:ZLNA) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial Insights

2 months ago - GuruFocus

Q3 2025 Zelluna ASA Earnings Call Transcript

Q3 2025 Zelluna ASA Earnings Call Transcript

2 months ago - GuruFocus